Gregory R Friberg is EVP, Chief R&D Officer of BIOMARIN PHARMACEUTICAL INC. Currently has a direct ownership of 43,506 shares of BMRN, which is worth approximately $2.38 Million. The most recent transaction as insider was on Sep 30, 2025, when has been sold 3,304 shares (Common Stock) at a price of $54.16 per share, resulting in proceeds of $178,944. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.5K
0% 3M change
49.71% 12M change
Total Value Held $2.38 Million

Gregory R Friberg Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 30 2025
SELL
Payment of exercise price or tax liability
$178,944 $54.16 p/Share
3,304 Reduced 7.06%
43,506 Common Stock
Mar 17 2025
BUY
Grant, award, or other acquisition
-
17,750 Added 27.49%
46,810 Common Stock
Sep 30 2024
BUY
Grant, award, or other acquisition
-
29,060 Added 50.0%
29,060 Common Stock
GRF

Gregory R Friberg

EVP, Chief R&D Officer
San Rafael, CA

Track Institutional and Insider Activities on BMRN

Follow BIOMARIN PHARMACEUTICAL INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BMRN shares.

Notify only if

Insider Trading

Get notified when an Biomarin Pharmaceutical Inc insider buys or sells BMRN shares.

Notify only if

News

Receive news related to BIOMARIN PHARMACEUTICAL INC

Track Activities on BMRN